Answers are grounded in this paper and cite their sources.
Antiphospholipid antibody (aPL) testing is critical for the classification of antiphospholipid syndrome. The 2023 ACR/EULAR classification criteria recommend the use of enzyme-linked immunosorbent assays (ELISAs) and specific thresholds for aPL positivity. Since non-ELISA methods are increasingly used, we compared and evaluated ELISA and non-ELISA aPL assays in a real-world maximum care hospital setting.
No takes yet. Share an insight, caveat, or question.
Kocijančić et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: